Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuying Tian
Institution:
Chinese PLA General Hospital
Observed institutions:
Chinese PLA General Hospital,
Chinese People's Liberation Army,
Inner Mongolia Medical University
OpenAlex ID:
A5035309407
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
2022
·
Zhuoya Deng
, Yuying Tian
, et al.
·
Frontiers in Immunology
·
145
PDF
Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation
2023
·
Shuai Lu
, Xibo Sun
, et al.
·
Frontiers in Immunology
·
72
An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma
2022
·
Zhuoya Deng
, Hao Yang
, et al.
·
Frontiers in Oncology
·
49
PDF
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
2024
·
Yan Xu
, Fang Sun
, et al.
·
International Immunopharmacology
·
31
mRNA vaccines: A novel weapon to control infectious diseases
2022
·
Yuying Tian
, Zhuoya Deng
, et al.
·
Frontiers in Microbiology
·
31
PDF
NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment
2024
·
Liangzheng Chang
, Lei Xu
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
22
A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge
2024
·
Yuying Tian
, Zhuoya Deng
, et al.
·
Virology
·
15
A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response
2024
·
Cong Li
, Yuying Tian
, et al.
·
Human Gene Therapy
·
14
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus
2023
·
Zhao Yang
, Mengran Shi
, et al.
·
Journal of Gastroenterology
·
9
Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant
2023
·
Liangzheng Chang
, Yuying Tian
, et al.
·
Journal of Immunology Research
·
8
PDF
Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs
2025
·
Zhuoya Deng
, Yuying Tian
, et al.
·
International Journal of Nanomedicine
·
7
PDF
An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma
2024
·
Hao Yang
, Guanglin Lei
, et al.
·
Journal of Hepatocellular Carcinoma
·
5
PDF
Nanoadjuvant and recombinant hemagglutinin protein-based mucosal influenza nanovaccine confers protection against lethal viral challenge in mice
2026
·
Yongru Xu
, Dongmei Wu
, et al.
·
International Journal of Biological Macromolecules
Show more works
View as search
Works count:
13
Citation count:
408
H-index:
9
I10-index:
8
Year
Topic
Type